AfterRaise/Companies/EMED Technologies' Subsidiary

EMED Technologies' Subsidiary

USAEl Dorado HillsBiotech & PharmaUndisclosed

Overview

Where EMED Technologies' Subsidiary is now

EMED Technologies' Subsidiary announced a funding round of $8M on 25 February 2026.

Observed Described in the funding announcement as "developer of drug delivery and innovative infusion therapy devices". Source

Latest round
Undisclosed
Amount
$8M
Announced
25 February 2026
Headquarters
El Dorado Hills, USA
Sector
Biotech & Pharma
Growth stage
Growth
Investors
Not stated
Also participating
Not stated
Relevant leadership
Not stated

Momentum Inferred

AfterRaise Score

27
Established
0 funding signals in the last 90 days
Funding recency
9/40
announced within the last year
Round scale
8/25
round size relative to the market
Funding stage
10/20
Undisclosed
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Growth timeline

What has happened so far

  • 25 February 2026
    $8M raised
    Investors not stated in the announcement.

Observed The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

Moves

Published by the company

Share a Move

No company-published Moves yet

AfterRaise has the funding facts for EMED Technologies' Subsidiary from public sources. What it does not have is what the company is doing next, in the company's own words. That part only they can write.

Work here? Publish the first Move

Opportunities

Work this company has opened

No open Opportunities listed

Jobs, projects, partnerships and advisory needs appear here once the company has claimed its room and published them.

Work here? Open the first one

Open to

Who may approach EMED Technologies' Subsidiary

Not yet specified

EMED Technologies' Subsidiary has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Work here?

This room belongs to EMED Technologies' Subsidiary.

Claim it to publish Moves in your own words, open Opportunities, choose who may approach you, and see the offers of help you have received. Everything you publish is reviewed before it appears.

Also moving

Other Biotech & Pharma companies

See the sector